Company news

CytomX Therapeutics, Inc. news in 2025

CytomX Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

CytomX Therapeutics to Present at Upcoming December Investor Conferences

November 24, 2025

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

November 12, 2025

CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

November 5, 2025

CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 3, 2025

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

October 29, 2025

CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer

October 19, 2025

CytomX Therapeutics to Present at Upcoming September Investor Conferences

August 27, 2025

CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study

August 12, 2025

CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

August 6, 2025

CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025

July 30, 2025

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

May 28, 2025

CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma

May 18, 2025

CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

May 11, 2025

CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

May 11, 2025

CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC)

May 11, 2025

CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025

May 4, 2025

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

April 27, 2025

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

March 5, 2025

CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference

March 4, 2025

CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

February 26, 2025

CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 7, 2025

CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update

January 5, 2025

Calls in 2025